BackInozyme Pharma Overview

Inozyme Pharma Total Assets

Track Inozyme Pharma's total assets ($95M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$95.16M
↓ 46.22% YoYΔ $-81.78M vs prior year quarter

Peer trimmed avg / median

Loading

Inozyme Pharma Total Assets History

Loading

Inozyme Pharma vs. peers: Total Assets Comparison

Loading

Inozyme Pharma Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Inozyme Pharma (INZY) FAQ

Inozyme Pharma (INZY) currently reports a total assets of $95M as of March 2025. That compares with $180M in the prior-year period — down 46.2% year over year. Use the charts on this page to explore Inozyme Pharma's total assets history and peer comparisons.

Inozyme Pharma's total assets decreased from $180M to $95M — a 46.2% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Inozyme Pharma reported $95M in total assets as of March 2025. That compares with $180M in the prior-year period — down 46.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $95M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Inozyme Pharma, and consider following INZY for alerts when major investors trade the stock.

Inozyme Pharma is classified in the Healthcare sector. On total assets, it currently shows $95M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INZY with unrelated industries.